← European Medicine Shortage Tracker · all medicines
Availability information only — Mobi Doctor doesn't sell medicines; check with a pharmacy.
Paliperidon palmitat currently has availability issues reported in 4 European registers: Austria, Germany, Greece, Sweden.
Shortage ATC N05AX13 · also listed as: PALIPERIDON PALMITAT · Paliperidonpalmitat · data refreshed 11 September 2026
As of 11 September 2026, 4 of the 9 tracked registers list current availability issues for Paliperidon palmitat, covering 15 affected product presentations. The longest-running open report was filed in Austria on 2025-05-07 and has now been open for about 16 months. Where agencies state a cause, manufacturing problems lead with 5 of the 6 stated-cause reports, followed by delivery delays with 1. The furthest expected-resolution date currently on file is 2027-03-07; the earliest is 2026-12-31. Notably, 1 report has already passed the expected-resolution date without closing — prognoses for this medicine should be read as estimates, not commitments. The issue spread across registers over time rather than at once: Austria reported first (2025-05-07), with Greece following roughly 15 months later — a pattern typical of supply problems cascading between national markets. Registers in Germany, Sweden indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching. In the WHO ATC classification, Paliperidon palmitat is coded N05AX13 — a medicine acting on the nervous system — so clinically related products appear under “Related medicines” below.
| Where | Status & products | Since | Expected end | Reason / alternatives | Source |
|---|---|---|---|---|---|
| 🇦🇹 Austria | Shortage Palibon 100 mg Depot-Injektionssuspension in einer Fertigspritze + 4 more productsPalibon 150 mg Depot-Injektionssuspension in einer Fertigspritze Palibon 25 mg Depot-Injektionssuspension in einer Fertigspritze Palibon 50 mg Depot-Injektionssuspension in einer Fertigspritze Palibon 75 mg Depot-Injektionssuspension in einer Fertigspritze | 2025-05-07 | — | — | register ↗ |
| 🇩🇪 Germany | Shortage Paliperidon Advanz Pharma 100 mg Depot-Injektionssuspension in einer Fertigspritze + 4 more productsPaliperidon Advanz Pharma 150 mg Depot-Injektionssuspension in einer Fertigspritze Paliperidon Advanz Pharma 25 mg Depot-Injektionssuspension in einer Fertigspritze Paliperidon Advanz Pharma 50 mg Depot-Injektionssuspension in einer Fertigspritze Paliperidon Advanz Pharma 75 mg Depot-Injektionssuspension in einer Fertigspritze | 2025-12-09 | 2027-03-07 | Probleme in der Herstellung Alternatives: N/A | register ↗ |
| 🇬🇷 Greece | Limited availability Paliperidonpalmitat | 2026-08-07 | 2026-08-17 | Καθυστέρηση παράδοσης περιεκτικότητας Εναλλακτικά άλλα σκευάσματα της | register ↗ |
| 🇸🇪 Sweden | Shortage Palmeux 100 mg Injektionsv., depotsusp. i förf. spruta + 3 more productsPalmeux 150 mg Injektionsv., depotsusp. i förf. spruta Palmeux 50 mg Injektionsv., depotsusp. i förf. spruta Palmeux 75 mg Injektionsv., depotsusp. i förf. spruta | 2025-12-09 | 2026-12-31 | — Alternatives: Alternative(s) available — see the national register. | register ↗ |
Every individual register entry for Paliperidon palmitat in the tracked sources, newest first — including resolved and discontinued reports.
| Reg. | Product | Status | Reported | Expected end | Stated reason |
|---|---|---|---|---|---|
| 🇬🇷 GR | Paliperidonpalmitat | Limited availability | 2026-08-07 | 2026-08-17 | Καθυστέρηση παράδοσης περιεκτικότητας Εναλλακτικά άλλα σκευά |
| 🇦🇹 AT | Palibon 100 mg Depot-Injektionssuspension in einer Fertigspritze | Shortage | 2026-01-07 | — | |
| 🇦🇹 AT | Palibon 150 mg Depot-Injektionssuspension in einer Fertigspritze | Shortage | 2026-01-07 | — | |
| 🇦🇹 AT | Palibon 50 mg Depot-Injektionssuspension in einer Fertigspritze | Shortage | 2026-01-07 | — | |
| 🇦🇹 AT | Palibon 75 mg Depot-Injektionssuspension in einer Fertigspritze | Shortage | 2026-01-07 | — | |
| 🇩🇪 DE | Paliperidon Advanz Pharma 100 mg Depot-Injektionssuspension in einer F | Shortage | 2025-12-09 | 2027-03-07 | Probleme in der Herstellung |
| 🇩🇪 DE | Paliperidon Advanz Pharma 150 mg Depot-Injektionssuspension in einer F | Shortage | 2025-12-09 | 2027-03-07 | Probleme in der Herstellung |
| 🇩🇪 DE | Paliperidon Advanz Pharma 25 mg Depot-Injektionssuspension in einer Fe | Shortage | 2025-12-09 | 2027-03-07 | Probleme in der Herstellung |
| 🇩🇪 DE | Paliperidon Advanz Pharma 50 mg Depot-Injektionssuspension in einer Fe | Shortage | 2025-12-09 | 2027-03-07 | Probleme in der Herstellung |
| 🇩🇪 DE | Paliperidon Advanz Pharma 75 mg Depot-Injektionssuspension in einer Fe | Shortage | 2025-12-09 | 2027-03-07 | Probleme in der Herstellung |
| 🇸🇪 SE | Palmeux 100 mg Injektionsv., depotsusp. i förf. spruta | Shortage | 2025-12-09 | 2026-12-31 | |
| 🇸🇪 SE | Palmeux 150 mg Injektionsv., depotsusp. i förf. spruta | Shortage | 2025-12-09 | 2026-12-31 | |
| 🇸🇪 SE | Palmeux 50 mg Injektionsv., depotsusp. i förf. spruta | Shortage | 2025-12-09 | 2026-12-31 | |
| 🇸🇪 SE | Palmeux 75 mg Injektionsv., depotsusp. i förf. spruta | Shortage | 2025-12-09 | 2026-12-31 | |
| 🇦🇹 AT | Palibon 25 mg Depot-Injektionssuspension in einer Fertigspritze | Shortage | 2025-05-07 | — |
Yes. As of 11 September 2026, availability issues are reported in: Austria, Germany, Greece, Sweden. Availability is national — a shortage in one country does not mean it is short everywhere.
Agency prognoses on file range from 2026-12-31 to 2027-03-07. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.
9 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.
Directly from the official medicines-agency registers that list Paliperidon palmitat: BASG (Austria), BfArM (Germany), EOF limited-availability list (Greece), Läkemedelsverket (Sweden). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.
Pharmacies, patient sites and newsrooms are welcome to embed the live status of Paliperidon palmitat — free, with attribution. Copy this snippet:
<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/paliperidon-palmitat/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Paliperidon palmitat availability in Europe"></iframe> <p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/paliperidon-palmitat/">Paliperidon palmitat shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>